Pen Needles Market: Growth, Size, Share, and Trends

Report Code MD 2851
Published in Oct, 2023, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Pen Needles Market by Type (Standard Pen & Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase, End User, Unmet Needs, Key Stakeholders, Buying Criteria - Global Forecast to 2028

Overview

The global pen needles market growth forecasted to transform from $1.6 billion in 2023 to $2.5 billion by 2028, driven by a CAGR of 9.1%.

Various factors such as the increasing shift of therapy to home settings, growing preference for biosimilar drugs, and emerging markets are likely to accelerate the growth of the market. Moreover, the presence of well-established key players focusing on improving the awareness regarding insulin delivery devices and their home use are likely to propel the market growth during the forecast period

Attractive Opportunities in the Pen Needles Market

ASIA PACIFIC

Market growth in the Asia Pacific is attributed to the rising prevalence of diabetes, improving healthcare expenditure, and the rising disposable income.

The growth of this market is driven by the growing prevalence of chronic diseases, a favorable reimbursement scenario in select countries, growing adoption of self-administration, and decreasing price of insulin formulations and related devices by major players are driving the growth of this market.

The safety pen needles segment is estimated to grow at a higher CAGR during the forecast period, as they are more affordable, especially considering the need for daily insulin intake.

The 4mm pen needles market is projected to witness the highest growth rate during the forecast period due to their wide usage for painless injections.

The preference for alternative modes of drug delivery, poor reimbursement in developing countries, and needle anxiety restrain the market growth.

Global Pen Needles Market Dynamics

Driver: Growing adoption of self-administration

Due to the advantages that pen injectors offer over conventional drug administration methods using vials and syringes include ease of use, especially at home, which eliminates the need for frequent trips to clinics or healthcare facilities. Pen injectors also offer a low risk of errors while administering the correct dose. Pen injectors can reduce pain at the injection site, especially if used with shorter pen needles, and improve the quality of life compared to other drug delivery modes.

These advantages are expected to drive market growth during the forecast period.

Restraint: Preference for alternative modes of drug delivery

Some of the problems associated with using pen needles include needlestick injuries and infections, hyperglycemia, and pain. Due to inability to regulate the dosage, these are sometimes associated with hyperglycemia. Therefore, in some regions, insulin pumps are preferred over pens for administering insulin. This is one of the major restraints facing the pen needles market.

 

Opportunity: Emerging markets

Emerging markets such as those in China, India, Mexico, and Brazil are fast-growing pen needle markets. The growing prevalence of diabetes, the growing healthcare expenditure, and diabetes treatment awareness, growing per capita income, and increasing R&D initiatives to develop innovative medical technologies are some of the factors driving these regional markets. Not only that, from the supply side perspective, cheap labor and low-cost manufacturing are major advantages for key market players.

Challenge: Reuse of pen needles

Reuse of pen needles is a major challenge in the pen needles market. Although manufacturers’ instructions advise against it, reuse of pen needles varies across geographies from as low as 30% to a staggering 95% of patients reusing their needles. According to a study published in Value Health Journal, about 98.35% of patients reuse insulin pen needles in China. Reasons for this stem mostly from inability to afford regular purchases. Most developing countries don’t have insurance coverage for pen needles, which makes it even more difficult to use fresh pen needles for every injection.

Global Pen Needles Market Ecosystem Analysis

The ecosystem of the pen needles market comprises elements present in this market and defines these elements with a demonstration of the bodies involved. It includes manufacturers, distributors, research & product developers, and end users.

 

By type, safety pen needles segment is expected to grow at the higher CAGR during the forecast period.

The largest share of the pen needles by type is occupied by standard pen needles in 2022. This can be attributed to the lower cost, especially considering pen needles need to be bought regularly, and therefore, becomes a recurring cost. However, as standard needles are not equipped with safety shields, the risk of accidental needlestick injuries (NSIs) with these needles is high. Therefore, the demand for safety pen needles is expected to grow considerably in the coming years due to growing concerns regarding the prevention of NSIs, making it the segment with the higher CAGR.

The insulin therapy is witnessed to have highest growth rate of the pen needles market, by application during the forecast period.

In the pen needles market, the GLP-1 therapy segment is expected to grow at the fastest rate after insulin therapy during the forecast period. The high growth rate of the GLP-1 therapy segment can be attributed to the rapidly rising incidence of type 2 diabetes, and the increasing patient awareness on newer therapies and injectables to manage diseases.

North America is Projected to be the Largest Regional Market for Pen Needles

North America dominates the pen needles market. The North American region is gaining traction with the increasing incidence and prevalence of chronic diseases. Moreover due to strong foothold of major key players in the region, rising approval of pen injectors for multiple applications across many countries, and initiatives by government to increase the awareness about the advancements in insulin drug delivery are likely to play a major role in fueling the growth of the pen needles market in North America

HIGHEST CAGR MARKET IN 2023
US FASTEST GROWING MARKET IN THE REGION

Recent Developments of Pen Needles industry

  • In February 2023, Montmed, Inc. (Canada) announced issuance of a second US Patent for Sitesmart Pen Needles.
  • In April 2022, Embecta Corp. (US) completed the spin-off from Becton, Dickinson and Company (US) and started operating globally as a standalone pure-play diabetes care company.
  • In February 2021, UltiMed, Inc. (US) launched UltiCare safety pen needles in two sizes, 5mm 30G and 8mm 30 G.
  • In January 2021, NHS (UK) chose Owen Mumford (UK) as the sole supplier of safety pen needles. With this partnership, Owen’s pen needles will be used in all NHS Wales hospitals.

Key Market Players

KEY PLAYERS IN THE PEN NEEDLES MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Pen Needles Market?

Scope of the Report

Report Attribute Details
Market size available for years 2021–2028
Forecast units Value (USD)
Segments Covered Application, Type, Setting, Mode of Purchase, Region, and Length
Geographies covered Europe (Germany, the UK, France, Italy, Spain, and RoE), North America (US & Canada), LATAM (Brazil, Mexico, and RoLATAM), APAC (Japan, China, Australia, South Korea India, and the RoAPAC), and MEA

Key Questions Addressed by the Report

What are the drivers for the pen needles market?
A favorable reimbursement scenario in select countries and decreasing price of insulin formulations and related devices by major players are likely to propel the market growth, among other factors, during the forecast period. Additionally, the growing preference for biosimilar drugs, emerging markets, increasing healthcare expenditure on diabetes care, and mandates pertaining to safety pen needles provide a wide range of growth opportunities for key players in the market.
By Type, which segment provides the most opportunity for growth?
By type, the safety pen needles segment is expected to grow at a faster rate, while the standard pen needles segment is set to occupy the larger market share, even during the forecast period. The fast growth of the safety pen needles segment can be attributed to the fact that many national and international organizations are recommending using safety syringes and needles to prevent needlestick injuries. Since pen needles are most often used at home without the presence of a healthcare professional, usage of pen needles gains even more importance.
Who are the leading vendors operating in this market?
Embecta Corp. (US), Novo Nordisk (Denmark), Ypsomed Holding AG (Switzerland), and B. Braun Melsungen AG (Germany) are some of the leading players in the pen needles market.
Which region is expected to witness significant demand for pen needles in the coming years?
The Asia Pacific is the fastest-growing geographic segment in the pen needles market, during the forecast period. This is attributed to the rising population base with chronic diseases, especially diabetes, increase in the healthcare expenditure, growing utilization of pen injectors, and lower manufacturing costs in the region.
What is the impact of recession on pen needles market in the coming years?
Since diabetes is a chronic condition which requires daily injections, the existing demand for pen needles is expected to remain stable during the recession. However, other cheaper methods of administering insulin, including syringes, might become the better choice for new users.

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Pen Needles Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
23
RESEARCH METHODOLOGY
29
EXECUTIVE SUMMARY
43
PREMIUM INSIGHTS
47
MARKET OVERVIEW
50
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising incidence of chronic diseases
    - Favorable reimbursements in mature markets
    - Growing adoption of self-administration
    - Decreasing prices of insulin formulations
    RESTRAINTS
    - Alternative methods of drug delivery
    - Poor reimbursements in emerging markets
    - Needle anxiety
    OPPORTUNITIES
    - Growing preference for biosimilar drugs
    - High-growth potential of emerging economies
    - Rising healthcare expenditure on diabetes
    - Regulatory mandates for safety pen needles
    CHALLENGES
    - Reuse of pen needles
    - Misuse of injection pens
  • 5.3 REIMBURSEMENT SCENARIO
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE FOR PEN NEEDLES, BY TYPE
    AVERAGE SELLING PRICE TRENDS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM/MARKET MAP
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.8 SUPPLY CHAIN ANALYSIS
  • 5.9 REGULATORY ANALYSIS
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - Japan
    - China
    - India
    REGULATORY BODIES, GOVERNMENT AGENCIES,
  • 5.10 HS CODES: PEN INJECTORS
  • 5.11 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR PEN NEEDLES
    INSIGHTS: JURISDICTION AND TOP APPLICANTS ANALYSIS
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.13 CASE STUDY ANALYSIS
  • 5.14 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGY
    - Fluid flow enhancement technology
    COMPLEMENTARY TECHNOLOGY
    - Microfabricated needles
    - AI in pen injectors
    ADJACENT TECHNOLOGY
    - Autoinjectors
  • 5.15 KEY CONFERENCES AND EVENTS
  • 5.16 ADJACENT MARKETS ANALYSIS
  • 5.17 USER REQUIREMENTS IN PEN NEEDLES MARKET
PEN NEEDLES MARKET, BY TYPE
84
  • 6.1 INTRODUCTION
  • 6.2 STANDARD PEN NEEDLES
    GROWING PREFERENCE DUE TO LOW COSTS TO DRIVE MARKET
  • 6.3 SAFETY PEN NEEDLES
    CONCERNS ASSOCIATED WITH NEEDLESTICK INJURIES TO PROPEL MARKET
PEN NEEDLES MARKET, BY LENGTH
90
  • 7.1 INTRODUCTION
  • 7.2 8MM
    WIDE ADOPTION IN NORTH AMERICA TO BOOST DEMAND
  • 7.3 5MM
    SHORTER LENGTH TO FUEL UPTAKE
  • 7.4 6MM
    FAVORABLE REIMBURSEMENTS TO BOOST DEMAND
  • 7.5 4MM
    WIDE ADOPTION AMONG CHILDREN FOR INSULIN DELIVERY TO DRIVE DEMAND
  • 7.6 12MM
    HIGH UTILIZATION OF SHORTER NEEDLES TO LIMIT ADOPTION
  • 7.7 10MM
    PAINFUL ADMINISTRATION TO RESTRAIN ADOPTION
PEN NEEDLES MARKET, BY APPLICATION
101
  • 8.1 INTRODUCTION
  • 8.2 INSULIN THERAPY
    RISING INCIDENCE OF DIABETES TO PROPEL MARKET
  • 8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY (GLP-1 THERAPY)
    GROWING FOCUS OF PHARMA COMPANIES ON GLP-1-BASED THERAPIES TO DRIVE MARKET
  • 8.4 GROWTH HORMONE THERAPY
    RECURRING REQUIREMENT OF INJECTIONS TO RESTRAIN MARKET
  • 8.5 OSTEOPOROSIS
    RISING VITAMIN D DEFICIENCY CASES TO PROPEL MARKET
  • 8.6 OTHER APPLICATIONS
PEN NEEDLES MARKET, BY SETTING
109
  • 9.1 INTRODUCTION
  • 9.2 HOME CARE SETTINGS
    GROWING PREFERENCE FOR SELF-ADMINISTRATION OF INSULIN TO PROPEL MARKET
  • 9.3 HOSPITALS AND CLINICS
    INCREASING ADOPTION OF SAFETY PEN NEEDLES TO DRIVE MARKET
  • 9.4 OTHER SETTINGS
    PEN NEEDLES MARKET, BY MODE OF PURCHASE
PEN NEEDLES MARKET, BY MODE OF PURCHASE
113
  • 10.1 INTRODUCTION
  • 10.2 PRESCRIPTION-BASED PURCHASE
    RETAIL PURCHASES TO SUPPORT MARKET GROWTH
  • 10.3 OVER-THE-COUNTER PURCHASE
    DISCOUNTS OFFERED BY LOCAL PHARMACIES, SUPPLIERS,
  • 10.4 ONLINE PURCHASE
    CONVENIENT TIME-EFFICIENT BENEFITS TO PROPEL MARKET
  • 10.5 OTHER MODES OF PURCHASE
PEN NEEDLES MARKET, BY REGION
121
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    US
    - Favorable reimbursements to propel market
    CANADA
    - Rising prevalence of diabetes to drive market
    NORTH AMERICA: RECESSION IMPACT
  • 11.3 EUROPE
    GERMANY
    - High healthcare spending to propel market
    UK
    - NHS support and growing access to cost-effective pen needles to drive market
    FRANCE
    - Favorable health insurance system to propel market
    ITALY
    - Low product pricing to support market growth
    SPAIN
    - Supportive regulations mandating the use of safety pen needles to propel market
    REST OF EUROPE
    EUROPE: RECESSION IMPACT
  • 11.4 ASIA PACIFIC
    JAPAN
    - Supportive reimbursement policies and universal healthcare coverage to propel market
    CHINA
    - Large patient population and healthcare infrastructure improvements to drive market growth
    AUSTRALIA & NEW ZEALAND
    - High healthcare expenditure to support market growth
    INDIA
    - Healthcare infrastructural improvements and rising disease burden to propel market
    SOUTH KOREA
    - Rising incidence of obesity and hypertension to support market growth
    SOUTHEAST ASIA
    - Growing awareness about diabetes to propel market
    REST OF ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
  • 11.5 LATIN AMERICA
    BRAZIL
    - Growing adoption of safety pen needles to drive market
    MEXICO
    - Low coverage for core health services to restrain market
    ARGENTINA
    - High out-of-pocket expenditure on insulin products to restrain market
    REST OF LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
  • 11.6 MIDDLE EAST & AFRICA
    INITIATIVES TO ENHANCE HEALTHCARE ACCESSIBILITY TO SUPPORT MARKET GROWTH
    MIDDLE EAST & AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
187
  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES
  • 12.3 REVENUE SHARE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS
  • 12.5 COMPANY EVALUATION MATRIX (2022)
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT
  • 12.6 START-UP/SME EVALUATION MATRIX (2022)
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
  • 12.7 COMPETITIVE SCENARIOS AND TRENDS
    PRODUCT LAUNCHES
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
202
  • 13.1 KEY PLAYERS
    EMBECTA CORP. (PART OF BD)
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    NOVO NORDISK A/S
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    YPSOMED AG
    - Business overview
    - Products offered
    - MnM view
    B. BRAUN MELSUNGEN AG
    - Business overview
    - Products offered
    - MnM view
    TERUMO CORPORATION
    - Business overview
    - Products offered
    - MnM view
    NIPRO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    OWEN MUMFORD
    - Business overview
    - Products offered
    - Recent developments
    ARKRAY, INC.
    - Business overview
    - Products offered
    - Recent developments
    ULTIMED, INC.
    - Business overview
    - Products offered
    - Recent developments
    HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.
    - Business overview
    - Products offered
    MONTMED, INC.
    - Business overview
    - Products offered
    - Recent developments
    HTL-STREFA
    - Business overview
    - Products offered
    ALLISON MEDICAL, INC.
    - Business overview
    - Products offered
    GLUCORX LIMITED
    - Business overview
    - Products offered
    BERPU MEDICAL TECHNOLOGY CO., LTD.
    - Business overview
    - Products offered
    ADVACARE PHARMA
    - Business overview
    - Products offered
    ARTSANA GROUP
    - Business overview
    - Products offered
    PROMISEMED MEDICAL DEVICES INC.
    - Business overview
    - Products offered
    TRIVIDIA HEALTH, INC.
    - Business overview
    - Products offered
    VOGT MEDICAL VERTRIEB GMBH
    - Business overview
    - Products offered
  • 13.2 OTHER PLAYERS
    VAN HEEK MEDICAL
    SIMPLE DIAGNOSTICS
    IYON MEDICAL
    LINKS MEDICAL PRODUCTS, INC.
    MHC MEDICAL PRODUCTS, LLC
APPENDIX
241
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 RISK ASSESSMENT ANALYSIS
  • TABLE 3 REIMBURSEMENT OF PEN NEEDLES, BY COUNTRY
  • TABLE 4 PRICING OF PEN NEEDLES, BY KEY PLAYERS
  • TABLE 5 PEN NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 10 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL
  • TABLE 11 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 PEN INJECTORS MARKET: MAJOR PATENTS
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES
  • TABLE 18 KEY BUYING CRITERIA FOR PEN NEEDLES
  • TABLE 19 CONTRIBUTION OF SMART INSULIN PENS FOR DIABETES MANAGEMENT
  • TABLE 20 PEN NEEDLES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023−2024)
  • TABLE 21 PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 22 PEN NEEDLES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
  • TABLE 23 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 24 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 25 STANDARD PEN NEEDLES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
  • TABLE 26 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 27 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 28 SAFETY PEN NEEDLES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
  • TABLE 29 PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 30 8MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 31 8MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 32 5MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 33 5MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 34 6MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 35 6MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 36 4MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 37 4MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 38 12MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 39 12MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 40 10MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 41 10MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 42 PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 43 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 44 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 45 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 46 PEN NEEDLES MARKET FOR OSTEOPOROSIS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 47 PEN NEEDLES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 48 PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 49 PEN NEEDLES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 50 PEN NEEDLES MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 51 PEN NEEDLES MARKET FOR OTHER SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 52 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 53 PEN NEEDLES MARKET FOR PRESCRIPTION-BASED PURCHASE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 54 PEN NEEDLES MARKET FOR OVER-THE-COUNTER PURCHASE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 55 PEN NEEDLES MARKET FOR ONLINE PURCHASES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 56 PEN NEEDLES MARKET FOR OTHER MODES OF PURCHASE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 57 PEN NEEDLES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 58 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 59 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 60 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 61 NORTH AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 62 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 63 NORTH AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 64 US: MACROECONOMIC INDICATORS
  • TABLE 65 US: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 66 US: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 67 US: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 68 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 69 US: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 70 CANADA: MACROECONOMIC INDICATORS
  • TABLE 71 CANADA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 72 CANADA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 73 CANADA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 74 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 75 CANADA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 76 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 77 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 78 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 79 EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 80 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 81 EUROPE: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 82 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 83 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 84 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 85 GERMANY: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 86 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 87 GERMANY: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 88 UK: MACROECONOMIC INDICATORS
  • TABLE 89 UK: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 90 UK: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 91 UK: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 92 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 93 UK: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 94 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 95 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 96 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 97 FRANCE: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 98 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 99 FRANCE: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 100 ITALY: MACROECONOMIC INDICATORS
  • TABLE 101 ITALY: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 102 ITALY: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 103 ITALY: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 104 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 105 ITALY: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 106 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 107 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 108 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 109 SPAIN: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 110 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 111 SPAIN: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 112 REST OF EUROPE: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 113 REST OF EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 114 REST OF EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 115 REST OF EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 116 REST OF EUROPE: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 119 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 121 ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 123 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 124 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 125 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 126 JAPAN: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 127 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 128 JAPAN: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 129 CHINA: MACROECONOMIC INDICATORS
  • TABLE 130 CHINA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 131 CHINA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 132 CHINA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 133 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 134 CHINA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 135 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 136 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 137 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 138 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 139 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 140 INDIA: MACROECONOMIC INDICATORS
  • TABLE 141 INDIA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 142 INDIA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 143 INDIA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 144 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 145 INDIA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 146 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 147 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 148 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 149 SOUTH KOREA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 150 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 151 SOUTH KOREA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 152 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 153 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 154 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 155 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 156 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 157 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 158 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 159 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 160 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 161 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 162 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 163 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 164 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 165 LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 166 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 167 LATIN AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 168 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 169 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 170 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 171 BRAZIL: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 172 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 173 BRAZIL: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 174 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 175 MEXICO: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 176 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 177 MEXICO: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 178 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 179 MEXICO: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 180 ARGENTINA: MACROECONOMIC INDICATORS
  • TABLE 181 ARGENTINA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 182 ARGENTINA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 183 ARGENTINA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 184 ARGENTINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 185 ARGENTINA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 186 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 187 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 188 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 189 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 190 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 191 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 192 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)
  • TABLE 193 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 194 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)
  • TABLE 195 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)
  • TABLE 196 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PEN NEEDLES MARKET
  • TABLE 197 PEN NEEDLES MARKET: OVERALL COMPANY FOOTPRINT (20 COMPANIES)
  • TABLE 198 PEN NEEDLES MARKET: TYPE FOOTPRINT (20 COMPANIES)
  • TABLE 199 PEN NEEDLES MARKET: LENGTH FOOTPRINT (20 COMPANIES)
  • TABLE 200 PEN NEEDLES MARKET: APPLICATION FOOTPRINT (20 COMPANIES)
  • TABLE 201 PEN NEEDLES MARKET: REGIONAL FOOTPRINT (20 COMPANIES)
  • TABLE 202 PEN NEEDLES MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 203 PEN NEEDLES MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–OCTOBER 2023)
  • TABLE 204 PEN NEEDLES MARKET: DEALS (JANUARY 2020– OCTOBER 2023)
  • TABLE 205 PEN NEEDLES MARKET: OTHER DEVELOPMENTS (JANUARY 2020– OCTOBER 2023)
  • TABLE 206 EMBECTA CORP.: COMPANY OVERVIEW
  • TABLE 207 NOVO NORDISK A/S: COMPANY OVERVIEW
  • TABLE 208 YPSOMED AG: COMPANY OVERVIEW
  • TABLE 209 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
  • TABLE 210 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 211 NIPRO CORPORATION: COMPANY OVERVIEW
  • TABLE 212 OWEN MUMFORD: BUSINESS OVERVIEW
  • TABLE 213 ARKRAY: BUSINESS OVERVIEW
  • TABLE 214 ULTIMED, INC.: BUSINESS OVERVIEW
  • TABLE 215 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: BUSINESS OVERVIEW
  • TABLE 216 MONTMED, INC.: BUSINESS OVERVIEW
  • TABLE 217 HTL-STREFA: BUSINESS OVERVIEW
  • TABLE 218 ALLISON MEDICAL, INC.: BUSINESS OVERVIEW
  • TABLE 219 GLUCORX LIMITED: BUSINESS OVERVIEW
  • TABLE 220 BERPU MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
  • TABLE 221 ADVACARE PHARMA: BUSINESS OVERVIEW
  • TABLE 222 ARTSANA GROUP: BUSINESS OVERVIEW
  • TABLE 223 PROMISEMED MEDICAL DEVICES INC.: BUSINESS OVERVIEW
  • TABLE 224 TRIVIDIA HEALTH, INC.: BUSINESS OVERVIEW
  • TABLE 225 VOGT MEDICAL VERTRIEB GMBH: BUSINESS OVERVIEW
  • TABLE 226 VAN HEEK MEDICAL: COMPANY OVERVIEW
  • TABLE 227 SIMPLE DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 228 IYON MEDICAL: COMPANY OVERVIEW
  • TABLE 229 LINKS MEDICAL PRODUCTS, INC.: COMPANY OVERVIEW
  • TABLE 230 MHC MEDICAL PRODUCTS: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY SETTING AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: EMBECTA CORP. (2022)
  • FIGURE 8 REVENUE ANALYSIS OF TOP FIVE COMPANIES: PEN NEEDLES MARKET (2022)
  • FIGURE 9 DEMAND-SIDE ANALYSIS
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 12 TOP-DOWN APPROACH
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 PEN NEEDLES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
  • FIGURE 15 PEN NEEDLES MARKET, BY LENGTH, 2023 VS. 2028 (USD MILLION)
  • FIGURE 16 PEN NEEDLES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
  • FIGURE 17 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2023 VS. 2028 (USD MILLION)
  • FIGURE 18 PEN NEEDLES MARKET, BY SETTING, 2023 VS. 2028 (USD MILLION)
  • FIGURE 19 GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 20 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
  • FIGURE 21 5MM SEGMENT TO DOMINATE ASIA PACIFIC MARKET
  • FIGURE 22 EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD
  • FIGURE 23 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • FIGURE 24 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN US, 1995–2030 (MILLION INDIVIDUALS)
  • FIGURE 26 TYPE 1 DIABETIC POPULATION, BY COUNTRY (2022)
  • FIGURE 27 AVERAGE SELLING PRICE OF PEN NEEDLES, BY TYPE
  • FIGURE 28 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 29 PEN NEEDLES MARKET: ECOSYSTEM/MARKET MAP
  • FIGURE 30 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 31 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS
  • FIGURE 32 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES
  • FIGURE 33 PATENT PUBLICATION TRENDS (JANUARY 2013–SEPTEMBER 2023)
  • FIGURE 34 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PEN NEEDLE PATENTS (JANUARY 2013–SEPTEMBER 2023)
  • FIGURE 35 TOP APPLICANT COUNTRIES FOR PEN NEEDLE PATENTS (JANUARY 2013– SEPTEMBER 2023)
  • FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES
  • FIGURE 37 KEY BUYING CRITERIA FOR PEN NEEDLES, BY TYPE
  • FIGURE 38 PEN NEEDLES MARKET: ADJACENT MARKETS
  • FIGURE 39 EMERGING MARKETS TO GROW AT HIGHER GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 40 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT
  • FIGURE 41 TOTAL FERTILITY RATE IN US POPULATION (1990−2021)
  • FIGURE 42 ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT
  • FIGURE 43 PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2021 VS. 2030)
  • FIGURE 44 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2020)
  • FIGURE 45 ELDERLY POPULATION IN SOUTHEAST ASIA (2022)
  • FIGURE 46 HEALTH EXPENDITURE OF COUNTRIES IN LATIN AMERICA FOR 2020 (% GDP)
  • FIGURE 47 REVENUE ANALYSIS FOR KEY COMPANIES IN LAST FIVE YEARS
  • FIGURE 48 PEN NEEDLES MARKET SHARE, BY KEY PLAYER (2022)
  • FIGURE 49 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (2022)
  • FIGURE 50 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS (2022)
  • FIGURE 51 EMBECTA CORP.: COMPANY SNAPSHOT (2022)
  • FIGURE 52 NOVO NORDISK A/S: COMPANY SNAPSHOT (2022)
  • FIGURE 53 YPSOMED AG: COMPANY SNAPSHOT (2022)
  • FIGURE 54 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
  • FIGURE 55 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 56 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)

The study involved four major activities to estimate the current size of the Pen Needles market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, regulatory bodies, and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), American Diabetes Association (ADA), American Association of Diabetes Educators (AADE), European Association for the Study of Diabetes] were referred to identify and collect information for the pen needles market study.

Primary Research

The pen needles market comprises several stakeholders such as manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies, original equipment manufacturing companies, suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies, healthcare service providers, teaching hospitals and academic medical centers, health insurance players, government bodies/municipal corporations, regulatory bodies, business research and consulting service providers, authorities framing reimbursement policies for pen needles, venture capitalists, and market research and consulting firms.

Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:

About the assumptions considered for the study, To know download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the pen needles market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Demand-Side Analysis (Bottom-Up Approach)

Top-Down Approach

Data Triangulation

After arriving at the market size, the total market was divided into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in the market engineering process.

Market Definition

A pen needle is a hollow needle entrenched in a plastic hub and attached to injectable pens. Pen needles are available in a wide range of lengths and diameters and can be used by healthcare professionals and patients to deliver injectable medications into the patient’s body. Pen needles are electro-polished for smooth, thin, and fine-point tips and provide comfort and ease in penetration; they serve as an alternative drug delivery technique to the traditional method of injecting drugs.

Key Stakeholders

  • Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
  • Original equipment manufacturing companies
  • Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
  • Healthcare service providers
  • Teaching hospitals and academic medical centers
  • Health insurance players
  • Government bodies/municipal corporations
  • Regulatory bodies
  • Business research and consulting service providers
  • Authorities framing reimbursement policies for pen needles
  • Venture capitalists
  • Market research and consulting firms

Report Objectives

  • To define, describe, and forecast the global pen needles market on the basis of length, application, type, setting, mode of purchase, and region.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for major market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa
  • To profile the key market players and comprehensively analyze their market shares and core competencies2
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, and expansions in the global pen needles market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the global pen needles market report :

Geographic Analysis

  • Further breakdown of the RoE pen needles market into Belgium, Russia, the Netherlands, Switzerland, and others.
  • Further breakdown of the RoAPAC pen needles market
  • Further breakdown of the RoLA pen needles market

Portfolio Assessment n

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies

Previous Versions of this Report

Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase (Retail, Non-Retail) - Global Forecast to 2026

Report Code MD 2851
Published in Oct, 2023, By MarketsandMarkets™

Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase (Retail, Non-Retail) - Global Forecast to 2026

Report Code MD 2851
Published in Jun, 2021, By MarketsandMarkets™

Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone, and Others), Mode of Purchase (Retail, Non-Retail) - Global Forecasts to 2023

Report Code MD 2851
Published in Feb, 2019, By MarketsandMarkets™

Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & Global Forecasts to 2021

Report Code MD 2851
Published in Jun, 2016, By MarketsandMarkets™

Pen Needles Market by Type (Standard and Safety), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), Therapy (Insulin, Glucagon-like peptide, Growth Hormones) - Analysis & Global Forecast to 2019

Report Code MD 2851
Published in Oct, 2014, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Pen Needles Market

User

Nov, 2019

how about Owen Mumford pen needle market? any chance their able grow more than others?.

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2024 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status